Studies supporting the approval of the majority of drugs used to treat attention-deficit/hyperactivity disorder (ADHD) in children were not designed to demonstrate long-term safety and efficacy of the drugs or detect rare adverse events (AEs), new research ...
from Meta Search Alerts http://ift.tt/1qhI6J1
via IFTTT
from Meta Search Alerts http://ift.tt/1qhI6J1
via IFTTT
No comments:
Post a Comment